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             ABSTRACT 
       Breast diseases is a common problem among females. Due to the high 
increase in the incidence of breast cancer in India, it is mandatory  to create 
awareness among the females. The common symptoms related to breast are 
pain, lump and heaviness of the breast.  
         In this study, 100 female patient of above 13 years of age of low socio 
economic groups attending the Surgery Out- patient Department of Coimbatore 
Medical College Hospital were studied. These patients had symptoms related to 
breast. Informed consent of the patients was obtained. They were subjected to 
the Triple assessment test consisting of clinical examination, radiological 
imaging and histopathological examination.  
        Based on this Triple assessment test analysis data, 74% of patients had 
benign lesions and 26%  of patients had malignant lesions of the breast. 
        Off the 74% of benign lesions, fibroadenoma was the commonest lesion 
accounting for 41%, followed by fibrocystic disease of breast-17%, phylloides 
tumour-6%, fibroadenosis-4%, keratocyst of breast-3%, breast abscess-2%, fat 
necrosis-1%. The youngest patient in this study was 17 years old , who was 
diagnosed as fibroadenoma. 
           All the 26 patients who was diagnosed as malignant disease had Invasive 
Ductal Carcinoma of the breast of different grades. This shows the rarity of 
other types of malignant lesions. The eldest patient in this study group was 68 
years old who was diagnosed as invasive ductal carcinoma. 
           Complete cure of the breast lesions, be it a benign or malignant, if 
diagnosed early, is possible. Hence screening and early detection play a vital 
role in alleviating  the patients  symptoms regarding breast. This study helps in 
creating awareness of the individuals for early detection and management of 
breast carcinoma. This study has a favourable effect in improving the outcome 
of women with breast lesions. 
 
  
KEY WORDS: 
       Fibroadenoma, Fibrocystic disease, Phylloides tumour, Fibroadenosis, 
Keratocyst of breast, Invasive ductal carcinoma, Breast abscess, Fat necrosis. 
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INTRODUCTION 
 
The incidence of Breast cancer is increasing worldwide. In India, it 
is the second most common malignancy
(1)
 in women accounting for about 
22.9%. This is next to carcinoma cervix uteri
(2)
 which accounts for nearly 
27%. 
 
In our country, breast malignancy accounts for about 1/6
th
 of the 
total mortality. There is about 1.4% annual incidence of this malignancy 
while there is a decreasing report in case of cancer cervix. 
 
Breast diseases have a wide spectrum of categorisation
 (3)
 and there 
is  also variations in their presenting complaints. Early malignant lesions 
can  be diagnosed earlier by the newer radiopathological techniques and  
radical cure of the disease is possible. 
 
Hence the awareness of the patient about the symptoms, screening 
and early diagnosis
(3)
 of  the disease will grossly change the outcome of 
the patients morbidity. 
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The Triple assessment which consists of clinical examination,  
imaging and FNAC/HPE provides a quick diagnosis and it alleviates the  
anxiety
(4) 
of the patients with benign lesions and early management of 
patients with malignant lesions. 
 
Since benign breast diseases and malignant lesions if diagnosed 
early,    complete curative treatment is possible, early detection of breast 
diseases  grossly reduce the morbidity and mortality in women. 
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HISTORICAL  REVIEW 
 
Breasts are considered by many females as a sign of feminity 
which are important to their sense of self.  In early days of European 
civilization
 (5)
, the sculptures of women with exaggerated or prominent 
breasts were common.  The organ was also famous in the Minoaon 
civilization in the form of the famous snake Goddess statuettes. 
 
The Smith Surgical Papyrus (3000- 2500 B.C)
 (6)
 is the earliest to 
document breast cancer. 
 
There was controversy about the surgical treatment of breast cancer 
throughout ancient times.  
 
Hippocrates
(7)
   argued  that  breast cancer was a systemic disease 
and that extirpation of  the primary tumor made matters worse
 
.   
 
Galen believed that breast cancer was a systemic disease and 
proposed the `humoral theory to account for its pathogenesis.   
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In the eighteenth and nineteenth centuries, several surgeons 
promulgated more aggressive surgical approach to the treatment of breast 
cancer. 
 
Jean Louis Petit (1674-1950), Director of the French Surgical 
Academy, first developed a unified concept for the surgical treatment of 
breast cancer
 (8) 
 
 
The modern surgical treatment of breast cancer has its origins in 
the mid nineteenth century.  Rudolf Virchow studied the morbid anatomy 
of breast cancer. He did not regard breast cancer as systemic at onset, but 
rather a local disease, amenable to cure with surgery. 
 
In 1894, Halsted and Mayer established radical mastectomy. 
In 1948, Patey and Dyson advocated a modified  radical  
mastectomy. 
In 1970, there was a change from the Halsteds radical mastectomy 
to the modified radical mastectomy
 (6)
. 
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ETYMOLOGY 
 
  The English word breast derives from the old English word 
breost (bosom) from the Proto Indo Europeon word bhreus
(5)
  meaning 
to  smell, to sprout. 
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AIM OF THE STUDY 
 
Aims and objectives of the study. 
 To study the profile of the breast diseases in females above 13 
years of age of low socio-economic status  attending  Surgery 
OPD in Coimbatore Medical College Hospital. 
 
 Early detection of proliferative lesions in these individuals. 
 
 Any particular geographical variations in their occurence. 
 
 To have a close follow up and careful watch  about the 
development of invasive cancer. 
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REVIEW OF LITERATURE 
 
EMBRYOLOGY 
 
At about 5
th
 or 6
th
 week of intrauterine gestation, the mammary 
ridge or the milk lines appear as two thickened cord like ectodermal 
structures.They extend from the future axilla to the region of the future 
inguinal region. 
 
The organ develops as an inpouch of the ectodermal tissues in  a    
primary tissue embedded in the parenchyma. The primary bud starts the 
growth of 15 -20 secondary buds. 
 
Epithelial cords develop from the secondary buds and penetrates 
into the surrounding mesenchymal tissues.  
 
The major lactiferous ducts drain into a mammary pit. After  
proliferation  of  the mesenchymal  tissues  this mammary  pit  is  
transformed  into nipple. 
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At the time of birth, the breasts of both males and females are 
indifferent. During the first week of birth there can be discharge from the 
nipple called witchs milk.  This is secreted in response to the maternal 
oestrogens that cross the placenta. 
 
 At the time of puberty, the development takes place due to the  
effect of the  ovarian estrogens and progestrone. 
 
However, the development is complete only at pregnancy. 
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ANATOMY 
Breast occupies a large portion of the superior part of the thorax 
and it is appears as an eminence
 (8)
. It extends laterally to a variable 
extent. Its shape and size are greatly determined by the genetic, racial and 
dietary factors and also the age, parity and the hormonal status of the 
individual. 
 
Though large variations are seen, mostly it extends from the second 
to the sixth rib vertically. Horizontally, it is from the lateral part of the 
sternal margin medially to the mid axillary line laterally. The upper outer 
quadrant may extend into the axilla by piercing the deep fascia- the 
axillary tail of Spence.  
 
The deep pectoral fascia lies posteriorly which in turn overlies the 
pectoralis major and the serratus anterior muscles superiorly and the 
external oblique muscle and its aponeurosis inferiorly.   
 
A space called sub-mammary space which contains loose areolar 
tissue lies between the breast and deep pectoralis fascia. This space is 
responsible for the movement of the organ over its fascia. 
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Fig 1 . ANATOMY OF BREAST 
 
 
 
Nipple   
 
It is an elevation proximally from the centre of the organ. In 
majority  of the individuals it occupies the 4
th
 intercostal space although 
there may be variations. 
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 Areola: 
 
  It is the hyperpigmented skin that is seen surrounding the pedicle 
of the nipple. The skin over the nipple areola complex has convoluted 
surface. They contain numerous sweat glands and sebaceous glands 
which gain access directly through the skin surface. Hair follicles are 
usually absent in the areola. 
 
The hyperpigmentation seen in the nipple-areola complex is due to 
presence of numerous melonocytes and hence they appear darker 
comparative to their surroundings.  
 
Soft tissue:  
 
Breasts are composed of numerous lobes. These lobes has 
glandular    structures consisting of branching ducts and secretory lobules 
which are embedded in the connective tissue stroma.  
 
 
The functional milk secretory component is the terminal duct 
lobular unit. Numerous  fibrous strands extend between the deep fascia of 
the thorax to the dermis.  
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These strands which are condensation of connective tissue are 
called Suspensory ligaments or the Astley Cooper ligaments. 
              
Arterial supply:   
 
Supplied by the branches of the axillary artery, the internal thoracic 
artery, and few intercostal arteries.  
 
Axillary artery supplies through the superior thoracic artery, the 
pectoral branches of the thoraco-acromial artery, the lateral thoracic 
artery and the subscapular artery. 
 
The perforating branches of the internal thoracic artery supplies the 
antero-medial region while that of 2
nd
, 3rd & 4
th
 intercostal arteries 
supply the lateral part. The 2
nd
 perforating artery is the largest of these. 
 
Venous Drainage: 
 
The venous drainage is to the internal thoracic and the axillary 
veins. Some occurs to the posterior intercostal vein which communicates 
to the internal vertebral venous plexus veins leading to metastatic spread 
to the bone
(9)
. 
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Lymphatic Drainage:     
 
75% of the lymphatic drainage to the breast  is to the axillary group 
of lymph nodes.  
 
The axillary nodes are grouped as anterior, posterior, central and 
apical nodes. Most of the drainage is to the anterior group. 
 
The inner  quadrants drain into the parasternal nodes 
accompanying the internal thoracic artery. A few drains into the posterior 
intercostals nodes or the interpectoral nodes also called the Rotters nodes 
which  lie between the Pectoralis major and minor muscles. 
 
In case of obstruction of the major channels by malignancy, the 
drainage occurs to the minor channels. Direct drainage to the supra 
clavicular lymphnodes is also possible. 
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Fig 2. LYMPHATIC DRAINAGE OF BREAST 
 
 
Levels of axillary nodes : 
Level I  :      Below and lateral to the pectoralis minor muscle   which  
  comprises the anterior, lateral and posterior groups. 
Level I  I:     Behind the pectoralis minor muscle – central group. 
Level III  :   Above and medial to the pectoralis minor muscle -apical   
    group of lymphnode. 
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Sentinel  Lymphnode  Biopsy: 
 
The first  lymphnode  which drains  the tumour area of the organ is 
defined as the “Sentinel lymph node”(11). 
 
Sentinel lymphnode biopsy plays an important role in case of early 
stage breast cancer.  It is used to determine the lymphnodes in case of 
early stage who are node negative clinically and by imaging modalities.     
   
 It is also useful in other  conditions like tumors with 
multicentricity, older age, obese patients,male breast malignancy, DCIS 
with mastectomy, for detection of internal mammary lymphnodes and 
before to the use of pre –surgical chemotherapy management.  
   
 The radioactive colloid
11
 is injected the day prior to surgery into  
either the subareolar tissue of the index quadrant of the breast or the      
peritumoral tissue or intraductal tissue near the primary tumor area. 
During surgery 3-5 ml of a vital blue dye is injected. Though any one 
method can be used to assess the sentinel node, many studies report that 
the combination of gamma probe detection of radioactive colloid and 
intraoperative utilisation of the blue dye is more sensitive and reliable, 
than depending on one method alone.  
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 The sentinel node is surgically removed for careful 
histopathalogical examination to detect the presence of metastasis. If 
negative, the radical sugery can be avoided in that patient and hence 
reducing the morbidity associated with the axillary clearance. 
 
 The overall benefit of sentinel node biopsy is around 97.2%. The 
false negative value is 9.8% and this was influenced by the site of 
tumour,the type of diagnostic biopsy and the number  of nodes excised 
during the surgery.  
 
 The complication of sentinel node biopsy are axillary seroma, 
haematoma
 
in the dissected region, wound infection, paraesthesia over the 
axilla, restricted movement of the arm and lymphedema.  
 
 Some patients may be allergic to the dye leading to anaphylactic 
reactions. 
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PHYSIOLOGY: 
 
The development of breast is dependent on the ovarian hormones 
estrogen & progesterone in the presence of pituitatory hormones. Large 
fluctuations in the hormones occur at puberty, during pregnancy and at 
the time of menopause. The growth of the ducts is dependent on 
estrogens, corticosteroids & pituitatory growth hormone. Prolactin plays a 
vital role in alveolar formation. 
 
Fig 3. LOBES OF BREAST 
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During lactation , the breast is dependent on prolactin, growth 
hormone and cortisol. Oxytocin hormone liberated by the posterior 
pituaitory promotes prolactin release and stimulates the myoepithelial 
cells to eject milk into the main duct system and the lactiferous sinus. All 
these changes get reversed as a result of weaning. 
 
Apart from pregnancy, the breasts of both nulliparous and 
multiparous women may produce milk which is termed galactorrhoea. 
This is mainly due to elevated levels of plasma levels of prolactin. This 
condition is different from nipple discharge which is a pathological 
condition. Differentiation requires assay of the fluid for milk proteins, 
lactalbumin and casein. 
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CLASSIFICATION OF BREAST DISEASES 
 
Breast diseases are classified broadly into  
  1. Benign Disorders 
2. Malignant Disorders 
Benign Breast disorders classification: 
  1. Congenital disorders 
   a. Amastia 
   b. Polymastia 
   c. Mastitis of Infants 
  2. Injury 
   a. Haematoma 
   b. Traumatic fat necrosis 
3. Inflammation or infection 
   a. Bacterial mastitis 
   b. Tuberculosis of the breast 
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   c. Actinomycosis of the breast 
   d. Hidradenitis suppurativa 
   e. Mondors disease 
4. ANDI (Aberrations of normal development and 
involution) 
   a. Cystic diseases of the breast 
   b. Fibroadenoma 
   c. Fibroadenosis 
  5. Duct ectasia or periductal mastitis 
  6. Pregnancy related lesions. 
   a. Galactocele 
   b. Puerperal abscess 
  7. Diseases not related to breast 
   a. Sebaceous cyst 
    b. Lipoma 
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1. Congenital Disorders: 
             AMASTIA:  
Refers to congenital absence of the breast. It may be unilateral or 
bilateral. It may be associated with Polands syndrome where there is 
congenital absence of the sternal portion of the pectoralis major. 
 
             POLYMASTIA:   
It refers to the presence of accessory nipple. It may be in the axilla 
which is the commonest or  the groin, buttock, and thigh. 
 
      MASTITIS OF INFANTS: 
True mastitis is very rare and it is commonly associated with 
Staphylococcus aureus. 
 
2. Injuries of the breast: 
       HAEMATOMA:   
A resolving haematoma give rise a lump which may be very 
difficult to diagnose especially if an overlying bruising is not seen. 
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         TRAUMATIC FAT NECROSIS :  
This is common in an obese, middle aged female. They usually 
present  with a painless lump. It may be caused by a trivial injury or due 
to an indirect violence to the pectoralis major.  
 
It may  mimic a carcinomatous  lesion as the history of injury could 
not be elicited due to unawareness of the patient about the injury. 
 
3.  Infections and inflammatory disorders: 
  BACTERIAL MASTITIS:   
  They are usually associated with lactation.Staphylococous aureus 
is the most common organism involved.  
 
 Breast abscesses usually present with point tenderness, erythema  
and  hyperthermia.  The lactiferous ducts will become blocked by 
epithelial debris leading to stasis.  
 
In acute cases, drainage by a circumareolar or incision parallel to 
the langerhans line is the management  In chronic mastitis, broad 
spectrum antibiotics is the treatment.  
 
Zuskas disease refers to recurrent periductal mastitis. 
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      TUBERCULOSIS OF THE BREAST:  
 Rare disease. Usually associated with acute pulmonary tuberculosis 
or tuberculous adenitis. Healing is usually delayed and mastectomy is 
advised for persistent residual infection. 
 
 ACTINOMYCOSIS:   
 Rarer disease.  
 It is associated with fascio cervical  actinomycosis. 
 
HIDRADENITIS SUPPURATIVA: 
This chronic inflammatory condition may affect the nipple-areola 
complex or axilla.  
 
The differential diagnosis are other chronic inflammatory    
conditions, pagets disease of the nipple or invasive breast cancer. 
 
Treatment is with antibiotic, incision and drainage of the lesion. 
 
 MONDORS DISEASE: 
 
  It is the thrombophlebitis of the superficial veins of the anterior  
chest wall and the breast.  
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It was described  by Mondor as “string phlebitis”. The thrombosed 
vein present as a tender, cord like structure and when the skin is stretched 
it  presence as a groove.  
The veins commonly involved are the internal thoracic vein, 
thoraco-epigastric vein or the superficial epigastric vein.  It is a self 
limiting disorder.  
Treatment consists of assurance, warm compression, anti 
inflammatory drugs and avoiding the  mobility of the arm. 
 
4. ANDI : (Aberrations of Normal Development and Involution) 
It is a new system of nomenclature of benign breast diseases 
described by the Cardiff Breast Clinic.  
It includes  fibrocystic disease, fibroadenosis, chronic mastitis and 
mastopathy. It includes all aspects of the breast condition including 
pathogenesis
(13)
 and the degree of abnormality. 
 Pathogenesis of “ANDI” varies from normal to well-defined 
disease processes. 
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Pathology of ANDI : 
The disease comprises of varying degrees and extent of   the 
following pathology. 
 Cyst formation 
 Fibrosis  
 Hyperplasia of epithelium 
 Papillomatosis 
    
Clinical Features of ANDI : 
 
The patients mainly present with symptoms of discrete lump, 
lumpiness and  or pain ( mastalgia ). 
 
 Discrete lump is usually seen in a cyst or a fibroadenoma. 
 
Lumpiness may be unilateral or bilateral. It usually affects the 
upper and outer quadrant. The symptom may be cyclical with both pain 
and lumpiness in the prementural period. 
 
Non cyclical mastalgia is common symptom of ANDI or periductal 
mastitis. It is common in the perimenopausal stage. 
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After excluding malignancy, the treatment for mastalgia consists of  
assurance, support of the organs by firm bra during the day and a softer 
one at night and to avoid caffeine. If these fails, medications consists of 
Evening primrose oil or Danozal 100 mg t.d.s. 
 
FIBROCYSTIC DISEASE OF BREAST   
 
Fibrocystic breast disease is a condition causing breast pain, cysts 
and non cancerous breast lumps, affecting many women. It is also known 
as fibroglandular changes, fibrocystic changes, chronic cystic mastitis, 
mammary dysplasia or benign breast disease. It is characterised by the 
presence of lumps in the breast which cause discomfort to the patient. 
They are often periodically related to the hormones from the menstural 
cycle. 
 
These benign masses are usually smooth with well defined edges 
and are freely mobile.  They usually occupy the upper and outer quadrant 
of the breast. Patients have an intermittent aching pain or breast 
tenderness related to periodic swelling. The symptoms are usually 
periodic in nature and they present mainly in the premenstrual time. 
Symptoms tend to peak just before the menstrual time and decreases 
afterwards. At the premenstrual stage the breasts may be full and swollen. 
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The exact etiology is unknown. Hormones play a role as the 
condition usually subsides after menopause and it is also related to the 
menstrual cycle. The most important of these hormones are oestrogen, 
progesterone and prolactin. These hormones are involved in the 
hyperplasia of the cells in the breast tissue. Several variants of fibrocystic 
breast changes may be distinguished according to their etiology and 
genetic predisposition.  
 
Diagnosis is primarily done by the symptoms and on clinical 
diagnosis. Fluid aspiration can be used to classify the fluid type.  
 
Treatment is rarely needed for this condition with no symptoms, 
but closer follow-up should be advised. In the presence of symptoms the 
treatment consists of assurance, advice to wear firm bra, oral or topical 
analgesics, Evening primerose oil and in retractable conditions treated 
with Danazol 100mg t.d.s. There is usually no adverse side effects to this 
condition. In most cases, it subsides after menopause. 
 
BREAST CYSTS: 
 This is common in the middle aged females. It may be multiple 
and also bilateral. It is diagnosed by ultrasound and or aspiration. 
Treatment comprise of aspiration of the cystic fluid. The two criteria to 
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diagnose as simple cysts are complete regression of the size after 
aspiration and absence of blood stained fluid. In case of doubt, 
cystadenocarcinoma should be ruled out which is common in 
postmenopausal women. 
 
FIBROADENOMA: 
 
 It is the most common benign disease in young individuals. It is 
common in the age group of 15 to 25 years. It is usually a self limiting 
lesion. It is due to hyperplasia of a single lobule. It is well encapsulated. 
 
Fibroadenoma  are lumps which are composed of both fibrous and 
glandular tissue. They are also called breast mouse or breast mice due to 
their high mobility within the breast tissue. They present as a painless, 
solitary, firm, mobile, slowly growing masses. They are usually 
diagnosed by clinical examination, radiology and often by the needle 
biopsy of the lump. 
 
 Fibroadenomas arise in the terminal duct lobular unit of the breast. 
They commonly occur in adolescent women. The incidence declines with 
increase of age. Fibroadenomas are partially hormone dependent and 
frequently regress after menopause. They are hypovascular compared to 
malignant tumors. 
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Macroscopically they are usually less than three cms in diameter. It 
can be round or ovoid, elastic and nodular. It has smooth surface. The cut 
section of the fibroadenoma mass appears firm and homogenous and they 
are gray-white ot tan in colour. The pericanalicular type has complete 
capsule while the intra canalicular type has an incomplete capsule. 
  
Microscopically they are composed of two elements- epithelium 
and stroma. Depending on the proportions of the presence of these tissues 
they are classified as intra-canalicular fibroadenoma and peri-canalicular 
fibroadenoma. 
 
In the intracanalicular fibroadenoma, there is predominance of the 
stromal proliferation which compresses the duct, which are irregular and 
reduced to slits. In the peri-canalicular type, there is predominance of 
fibrous stroma that proliferates around the ductal spaces, so that they 
appear oval or round on cross section. 
 
Confirmatory diagnosis is made by ultrasonography
(14)
 . 
 
The mainstay of treatment is conservative. The patient should be 
assured. Most of the excision of fibroadenomas in young individuals are 
done just to alleviate patient concern. 
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Most of the fibroadenomas can be left in-situ and the patient should 
be followed up. But some need treatment by surgical excision which 
consists of complete excision of the mass. Recurrence rate is very low 
following complete excision. 
 
Giant fibroadenomas are those of more than 5cm in diameter. They 
can be enucleated by a submammary cosmetically acceptable incision. 
 
 Recent trend in the management of fibroadenoma consists of 
echotherapy which uses high intensity focused ultrasound to destroy the 
fibroadenoma cells. This is a non-invasive technique. Also cryoablation 
which uses extreme cold to destroy tissue of the fibroadenoma is also 
tried for fibroadenoma management. This is a safe, effective and 
minimally invasive technique alternative to open surgical excision 
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5. Duct ectasia or periductal mastitis 
 
This is common in smokers. It is due to dilatation of the lactiferous 
duct which cause stagnation of the secretion in these dilated ducts. This 
may discharge. This discharge can irritate the surrounding structures 
leading to periductal inflammation. This inflammation may be severe that 
it can lead to abscess or fistula formation. 
 
 The common presenting symptoms are nipple discharge with or 
without nipple retraction, a  painful and tender small areolar mass, an 
abscess or a fistula. 
 
 If conservative management fails, the treatment consists of  
adfields operation which comprises of excision of all the major ducts. 
Zuskas disease is a special entity which refers to recurrent periductal 
mastitis. 
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MASTALGIA 
 
Mastalgia also called as mastodynia or mammalgia is a medical 
term of breast pain. The severity of breast pain may vary from a minor 
discomfort to a severely incapacitating pain.  
 
Mastalgia is classified into two main clinical patterns. 
 
1.  Cyclical mastalgia when the intensity of pain changes to the 
menstrual cycle. 
 
2.  Non-cyclical mastalgia when there is no change in pain to 
the menstrual cycle. 
 
Cyclical mastalgia is often associated with fibrocystic disease of 
breast or duct ectasia. It is due to the hormonal changes mainly due to the 
response of prolactin to thyrotropin. However some degree of cyclical 
breast tenderness is normal in the menstrual cycle. 
 
Non-cyclical breast pain can be due to hormonal changes in 
puberty, in menopause and during pregnancy. Breast pain is also common 
during lactation. Other conditions causing non-cyclical mastalgia are 
alcoholism with liver damages, mastitis and medications like digitalis, 
methyl dopa, spironolactone, certain diuretics, chlorpromazine, etc. 
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Treatment for cyclical mastalgia consists of systemic and topical 
application of Non-steroidal anti inflammatory drugs, progesterone, 
dopamine agonists, iodine, danazol, tamoxifen and ormeloxifene. The 
treatment for non-cyclical mastalgia varies according to its etiology. 
 
6.  Pregnancy related breast diseases:  
It includes Galactocele and puerperal abscess. 
 
GALACTOCELE  
It presents always during the lactation period. It is a rare condition. 
It mostly manifests as a solitary cyst in the sub-aeriolar region. The 
content is milk. In chronic cases, there occurs calcifications of its walls. 
 
PUERPERAL ABSCESS 
It occurs due to mastitis caused mainly due to the  methicillin 
resistant staphylococcus aureus that gets entry by the suckling neonate. 
There occurs pain, cracks or fissures in the nipple with stasis of milk. The 
management consists of stoppage of breast feeding, antibiotics and 
drainage if necessary. 
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PHYLLODES TUMOUR: 
 
The earlier nomenclature is serocystic disease of  Brodies or 
cystosarcoma phyllodes
(6)
.  
 
It commonly presents above the age of 40 years. 
  It is classified into  benign,  borderline or  malignant.  
The borderline variety is prone for recurrence. 
 
 Based on their  pathological status, they show a wide range of 
variations resembling that of fibroadenoma to that of malignancy. 
 
These tumours are sharply demarcated from the surrounding 
normal tissues. The tumour present as a large mass with a bosselated, 
uneven surface. The tumours show a mixed gelatinous, solid and cystic 
areas. 
 
Grossly, the cut section have the classical leaf like structure 
(phyllodes).The tumour present as a large mass with a bosselated, uneven 
surface. 
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Due to the pressure of the tumour there may be necrosis leading to  
ulceration of the underlying skin. 
 
The treatment in case of benign and borderline types is excision of  
the tumour with a margin clearance of 1cm. In case of malignant variety, 
massive sizes and recurrent lesions the treatment is mastectomy. The 
mode of metastases is via blood stream. Lymph node metastases is very 
rare and hence no role of axillary lymph node clearance in these cases.      
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CARCINOMA  BREAST 
It is the second most common cause of death in females in India
(1)
. 
Its incidence rate is on an increasing  level as compared to other 
malignancies. 
 
It is common in the upper outer quadrant of the breast. 
 
Etiological factors: 
 1. Age : 40- 60 years. 
 2. Breast Cancer Syndromes: 
  - Li- Fraumeni syndrome 
  - Cowdens  disease. 
  - Ataxia Telangectasia. 
3. Chromosomal abnormalities: 
  - BRCA 1 gene mutation. 
  - BRCA 2 gene mutation. 
  - HER 2 mutation. 
  - P53 mutation. 
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4. Diet : 
  - Alcohol 
  - Saturated fats 
5. Endocrine causes: 
  - Koreman’s  Hypothesis:  
 
Unopposed oestrogen with no progesterone that is present in 
early menarche and late menopause leads to anovulatory cycles. 
Hyperprolactinemia is inhibited in early childbirth. 
          
Increased incidence of Breast cancer is seen in: 
1. Early Menarche. 
2. Late Menopause. 
3. Late Child birth. 
4. Hormone replacement therapy. 
5. Absent Breast Feeding. 
6. Family History of : 
  -  Familial Breast Cancer. 
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  -  Sporadic Breast Cancer. 
  -  Hereditary Breast Cancer. 
TYPES OF BREAST CANCER: 
    I.  CARCINOMA In-Situ: 
  1. Ductal Carcinoma (DCIS) 
   a. Comedo. 
b. Intermediate. 
c. Non-Comedo 
    - Solid 
    - Cribriform 
    - Papillary 
        2. Lobular Carcinoma (LCIS) 
II.  INVASIVE  CARCINOMA: 
   1. Pagets disease of Nipple. 
   2. Invasive Ductal Carcinoma. 
   - Adenocarcinoma with productive fibrosis 80% 
          (Scirrhous, Simple, NST). 
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-  Medullary Carcinoma 4% 
   -  Mucinous (colloid) Carcinoma 2% 
   -  Papillary Carcinoma 10% 
3. Invasive Lobular Carcinoma 10% 
   4. Rare Types: 
   -  Adenoid cystic carcinoma 
    -  Squamous cell carcinoma 
   -  Apocrine carcinoma 
   -  Sarcomas 
    -   Lymphomas  
 
BLOOM & RICHARDSON’S GRADING 
 
      Grading of Carcinoma Breast is based on 
  1. Number of Mitosis (1-3). 
  2. Nuclear Pleomorphism (1-3) 
  3. Tubule formation (1-3) 
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Low Grade: 3 – 5 
  Egs: Tubular, Mucinous types. 
 Intermediate Grade: 6 – 7 
  Egs: Medullary, Lobular types 
High Grade: 8 – 9 
  Egs: NOS types. 
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TNM  STAGING OF BREAST CARCINOMA 
Primary Tumor (T) 
T0     -  No evidence of primary. 
Tis      -  Carcinoma in situ                                                                                                                    
         Pagets disease of Nipple with no mass palpable. 
T1     -  Tumor < 2cm in greatest dimension. 
T2     -  Tumor > 2cm but < 5cm in greatest dimension. 
T3     -  Tumor > 5 cm in greatest dimension. 
T4     -  Tumor of any size with extension to chest wall or skin. 
T4a   -  Extension to chest wall, not including pectoralis muscle. 
T4b  -  Edema (Peau d’orange), ulceration of the skin of  the   breast  
  and satellite skin nodules.                     
T4c   -   Both T4a and T4b. 
T4d   -  Inflammatory carcinoma. 
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     Regional Lymph nodes (N). 
 NX    -  Regional  lymph nodes  cannot  be  assessed. 
 N0    -  No regional lymph node metastasis. 
 N1    -  Metastasis to movable ipsilateral axillary lymph  
   nodes. 
 N2a  -  Metastasis to ipsilateral axillary nodes fixed to one  
   another or to other structures. 
N2b -  Metastasis to clinically apparent ipsilateral internal  
  mammary   nodes   in the absence of clinically  
  evident axillary nodes. 
N3a  -  Metastasis in ipsilateral infra clavicular lymph node  
  with or without axillary nodes. 
N3b  -  Metastasis in ipsilateral internal mammary  nodes and  
  axillary nodes. 
N3c  - Metastasis in ipsilateral supraclavicular lymph nodes  
  with or without axillary or internal mammary nodes. 
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Distant Metastasis (M) 
MX   -   Distant metastasis cannot be assessed. 
MO   -   No distant metastasis. 
M1   -   Distant metastasis 
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TNM STAGE GROUPINGS 
 
Stage I - T1  N0  M0 
 
 
 Stage IIA - T0  N1  M0;    T1 N1 M0;    T2  N0  M0 
 
 
 Stage IIB - T2  N1  M0;    T3  N0  M0. 
 
 
 Stage IIIA - T0  N2  M0;    T1  N2  M0;    T2  N2  M0;     
 
 
T3  N1  M0;    T3  N2  M0. 
 
 
 
 Stage IIIB - T4  N0  M0;    T4  N1  M0;    T4  N2  M0. 
 
 
 Stage IIIC - AnyT  N3  M0. 
 
 
 Stage IV - AnyT  AnyN  M1. 
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TREATMENT MODALITIES 
1. Total Mastectomy: 
- It consists of removal of all breast tissue, nipple-areolar 
complex and skin. 
- Prophylactic  Mastectomy done in case of BRCA 1& BRCA 2 
mutations. 
- Palliative  mastectomy is a type of simple mastectomy in cases 
of ulcerated Carcinoma breast. 
- Extended total  mastectomy consists of removal of all breast 
tissue, nipple-areolar complex, skin,level I axillary nodes. 
 
2.  Modified Radical Mastectomy (MRM): 
- It refers to removal of all breast tissue, nipple-areolar complex, 
skin, level I & level II axillary  nodes. 
 Pateys modification: 
Consists of division and   removal of Pectoralis minor along 
with Levels I, II, and III lymph nodes. 
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 Auchincloss modification: 
       Here the Pectoralis minor removed supero medially  and Level 
I & II nodes only are removed. 
 Scanlon modification: 
           In this type, the tendon of the Pectoralis minor muscle is 
divided at its insertion at the coracoids process and put it back after 
removal of the Level I , II, III Lymphnodes. 
 
The following strctures are preserved in Modified Radical 
Mastectomy 
  - Axillary vessels 
  - Bells nerve 
  - Cephalic vein 
  - Nerve to Latissimus dorsi 
  - Pectoralis major. 
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The advantages of MRM over Radical type are: 
- The shoulder function is preserved. 
- Pectoralis major is preserved, hence a good  vascular bed for skin 
flap. 
- Cosmetically acceptable as the axillary fold is preserved. 
 
3. Radical mastectomy 
    Halsteds Radical Mastectomy: 
- Consists of removal of breast tissue with nipple- areolar complex 
and Level I, II, III lymph nodes.Also the following structures are 
removed. 
- Pectoralis Major 
- Pectoralis Minor 
- Part of Serratus anterior 
- Latissimus dorsi 
- Subscapularis 
- Few fibres of the External oblique muscle 
- Upper part of Rectus abdominis. 
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The following structures are preserved: 
- Axillary  Nerves 
- Bell’s Nerve 
- Cephalic vein. 
 
Disadvantages: 
- Mutilating  surgery. 
- No bed for reconstruction. 
- Lymphedema of arms more common. 
- Poor cosmetic results. 
 
BREAST CONSERVATIVE SURGERY 
 It involves the following procedure. 
- Removal of the tumor with a wide margin. 
- Adjuvant  radiotheraphy. 
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The various surgical procedures employed are: 
- Segmental  excision. 
 - Lumpectomy 
- QUART (Quadrantectomy, Axillary node dissection and  
 Radio Therapy).   
 
Indications: 
 - When the lesion is solitary. 
- Possible to excise the tumor with tumor free    margins, 
without disrupting the tissues cosmetically. 
- No contraindications to radiotherapy (Eg.Pregnancy, 
Collagen vascular disorders, prior RT to same breast). 
 
Contraindications: 
- Presence of two or more lesions in separate areas. 
- Diffuse malignant appearing calcification. 
- History of prior radiation to breast. 
- Residual tumor, despite repeated resections. 
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- Multicentricity. 
- Inflammatory breast cancer. 
- Radiation therapy not possible. 
- Pregnancy in first  and second  trimesters. 
- Collagen vascular disorders. 
- Large tumor in a small breast. 
- Excision leading to cosmetically  unacceptable. 
     - Patients choice. 
 
The main aims of breast conservative therapy
(15)
 are 
- To reduce the amount of surgical impact on the patient. 
- to preserve a natural, good looking breast. 
- Efficient local treatment in regard to local control-free 
margins and prophylactic radiation therapy will guarantee 
the best possible success. 
 
Radiotherapy is an integral part of breast conservative therapy. It is 
critical to apply the necessary additional and prophylactic radiotherapy 
after the surgical procedures. 
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PROPHYLACTIC  MASTECTOMY 
 
The indications for prophylactic mastectomy
(15)
 of the contralateral 
breast are 
- Germ line BRCA1 and BRCA 2 mutations. 
- Strong family history of breast cancer with negative genetic testing. 
- Dense breasts that are difficult to image and examine. 
- History of multiple prior biopsies with pathology demonstrating 
proliferative changes with atypia. 
- Young age at diagnosis. 
- Patients who desire to avoid a second cancer.    
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CLINICAL EXAMINATION 
INSPECTION  :  
Postures of examining the breasts are : 
- Arms by the side of the patient. 
- Arms raised up in the air. 
- Hands on the hips 
- Alternating relaxation and contraction of the pectoralis  
muscle. 
 
The symmetry, size and shape of the breast are noted and any 
presence of edema (Peau d’orange)(6), retraction of skin or nipple or 
presence of erythema are recorded. Skin retraction is noted by asking 
the patient to lean forward with arms extended forward while sitting. 
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PALPATION : 
 
Palpation of the breast is done in the supine position with a pillow 
to support the ipsilateral hemithorax. All the quadrant of the breast are 
palpated gently with the palmar surface of the fingers. 
 
Palpation of the axillary nodes is done by supporting the arm and 
the elbow this stabilising the shoulder gridle. All the three levels of 
lymphnodes are palpated gently. This is followed by palpation for the 
supraclavicular and parasternal lymphnodes. 
 
PERCUSSION : 
 
This is usually done to find for the presence of internal mammary 
lymphnodes. 
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IMAGING MODALITIES 
  MAMMOGRAPHY 
  It is a plain X ray of the soft tissue using low voltage and high 
ampereage X-rays.   The two views are  
   1. Cranio caudal and 
   2. Mediolateral oblique. 
    It  delivers a radiation dose of 0.1 centi Gray cGy per study 
compared to an X-ray chest which delivers  only 25% of this dose. 
Fig 4. NORMAL MAMMOGRAM - I 
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Indications: 
1.   For screening purpose above the age 50yrs  or 40 yrs with 
risk  factor. 
2.  In obese patients. 
 3.  Already operated for one side. 
4.  When conservative surgeries are planned to rule out 
multifocal  involvement. 
5.  To find out the spread in the opposite breast.  
      6.  Mammography guided biopsy. 
7.  As a follow-up in benign breast disease with malignant  
 potential. 
 
Findings in case of benign diseases, the soft tissue shadow may be 
smooth and of regular margin. In malignancy, irregular margins are seen. 
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Findings relevant to cancer are: 
1.  Asymmetry 
2.  Presence of speculation. 
3.  Architectural distortion. 
4. Mass effect. 
5.  Branching calcification 
6.  Clustering 
7.  Micro calcification 
Fig 5. NORMAL MAMMOGRAM - II 
 
57 
 
 
Grading in Mammography : 
  Grade I :  Negative 
  Grade II :  Benign lesion 
  Grade III :  Probally benign lesion 
  Grade IV :  Suspicious  of malignancy 
  Grade V :  Breast carcinoma.  
 
  ULTRASONOGRAPHY: 
Ultrasonography  of the breasts are done in screening of young 
females
(14)
, when the mammographic results are equivocal, to define a 
cystic swelling and to specify the qualities of a solid mass. 
 
Breast cysts have smooth contours, hypoechoic lesions and 
well-defined margins. 
 
Malignant lesions have irregular walls with acoustic 
enhancement. 
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Advantages of ultra sound:  
- Used to guide for fine- needle aspiration biopsy and core-
needle biopsy. 
- Reports are highly reproducible. 
- Acceptance rate of the patient is high. 
 
Disadvantages: 
- It may not detect lesions less than 1cm in diameter. 
 
 MAGNETIC RESONANCE IMAGING: 
It remains a problem solving tool in breast imaging – to evaluate 
breasts with implants, detect recurrence and assess the breasts of patient 
with involved axillary nodes. 
 
It can also demonstrate axillary metastatic disease. Recently, it is 
gaining interest to screen individuals with a very strong family history of 
breast malignancy. It is done in patients of known breast cancers to find 
the presence of controlateral breast lesions. 
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 POSITIVE   EMISSION  TOMOGRAPHY:  
  
  It is a non invasive method of staging  the axilla. It involves the 
administration of a positron- labelled metabolic substrate intravenously 
which selectively accumulates in tumor cells compared to normal cells. 
Fluro-2-deoxy-D-glucose is the radio pharmaceutical agent commonly 
used. This technique is developing rapidly; However it is expensive and 
not widely available. Its results are promising, showing a sensitivity of 
75% and a specificity of  90% in recent studies. 
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BREAST  BIOPSY 
FINE NEEDLE ASPIRATION BIOPSY: 
Fine needle aspiration cytology has become a popular, valuable 
tool in the pre operative assessment of breast masses and it shows high 
accuracy, sensitivity and specificity. 
 
Because of its fast and easy approach it has gained a very popular 
role in the diagnosis of breast lesion. It is also inexpensive and can be 
done with minimal complications. FNAC plays a major role in 
differentiating benign and malignant lesions. It plays a vital role in the 
time honoured Triple assessment tests in the evaluation of breast masses. 
 
Nevertheless, in FNAC of breast lesions, differentiation of benign 
and malignant lesions may not be possible. This arises due to paucity of 
the sampling specimen or when there is a morphological overlap between 
the benign and malignant lesions as in atypical hyperplasia and low grade 
carcinoma in-situ or in papillary lesions. To accommodate these 
problems, cytological reporting categories are formulated. The most 
commonly used categorization is the five-tier system. 
 
 
61 
 
 
C 1 -   Insufficient sample 
C 2 -    Benign 
C 3 -    Atypical 
C 4 -   Suspicious of malignancy 
C 5 -    Malignant        
 
Benign breast lesions are usually easy to diagnose due to their 
obvious characteristic of the cytologic patterns. Hypocellularity, 
degenerated apocrine cells, necrosis and epithelial hyperplasia are some 
of the factors leading to difficulty in evaluating the smear, due to 
morphological overlap between the benign and malignant lesions. 
 
The false-negative rate though very less is due to poor sampling 
technique and poor localisation of the tumor. Small tumor size and non 
palpable breast lesions are also commonly associated with false-negative 
and aspirate inadequacy. 
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Procedure : 
 
Fig 6. FNAC PROCEDURE 
 
 
 
This is done in cases of palpable mass lesions
(12)
. A 22 gauge 
needle fitted to a 10 ml syringe is used. The mass is fixed with one hand. 
With the other hand, the needle is introduced into the mass and suction is 
applied while the needle is moved to and fro over the lesion.  
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Now the cellular material is expressed onto microscopic slides. 
 
 Fixation can be done either by air- free or by using 95% ethanol. It 
is a simple, safe and an out-patient procedure
(16, 17)
. 
 
CORE-NEEDLE BIOPSY : 
 
It is done in case of small lesions and clinically non-palpable 
lesions by means of image guidance. It provides information about the 
tissue architecture and whether the lesion is of invasive or not. In 
palpable lesion, it is performed using the 14 gauge needle, like Tru-cut 
needle. Tissue specimens are placed in formalin and  then processed to 
paraffin blocks.    
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MATERIALS AND METHODOLOGY 
 
MATERIALS AND DESIGN 
 Study design : 
 It is a prospective study. The  research population includes all 
females  above 13years of age, of low socio-economic status, attending 
surgical  OPD  of  Coimbatore Medical College Hospital. 
 
 
 Sample size: 
100 patients. 
 
 Inclusion criteria: 
    All female patients of age greater than 13 years, of low socio-
economic status with symptoms related to breast were included in the 
study. 
 
Duration of the study : 
 One year (November 2012 - November 2013). 
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Personnel: 
Surgeons of all units in Department of General Sugery. 
Pathologist 
Radiologist 
Nursing staff 
 
METHODOLOGY 
It is a prospective study.100 female patients above the age of 13 
yrs, of low socio economic status with symptomatic breast disease 
attending the General Surgery Out patient Department of Coimbatore 
Medical college Hospital were studied. 
 
Informed consent of the patient was obtained. Detailed history of 
the patient was recorded.  The patient was subjected to Triple assessment  
through clinical examination, imaging techniques comprising of USG, 
Mammogram and histopathological studies
(18)
. 
 
The safety of the patient is foremost.  They are subjected to 
minimal radiation exposure and invasive procedure. 
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The duration of the study was from  November 2012 to November 
2013. 
 
A complete statistical analysis of the patient was done. The patients 
data, mammography/ USG of breast findings and  Fine Needle Aspiration 
Cytology or histopathology reports were collected. These datas and 
reports were arranged on a dedicated spread sheet for personal computer 
input and subsequent analysis. 
 
Quality Assurance: 
All the study group females were assessed by the surgeons 
clinically.  
 
In case of doubt or expert  opinion, the guidance and opinions   of 
my Professors was obtained. 
 
Mammography or Breast ultrasound reports were given by the 
radiologist. To prevent any observers bias, a second opinion was obtained 
by another radiologist. The FNAC and Histopathological reports given by 
the pathologists were also verified by the second pathologist to avoid 
observers bias. 
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OBSERVATION AND RESULTS 
 
This study on the clinico-radio-pathological profile of breast 
disease was undertaken in a random of 100 female cases in a period of 
one year from November 2012 to November 2013. 
 
The study group included the females above 13 years of age of low 
socio-economic status who attended the surgical Out Patient Department 
of the Coimbatore Medical College Hospital. 
 
In this study the main presenting complaints of these patients were 
pain,presence of lump or heaviness of the breasts.Most of the younger 
patients presented earlier for clinical examination compared to the elder 
patients. This shows that the young females are more aware of the 
symptoms related to breast and they are self motivated in seeking clinical 
examination. 
 
First of all by this study, the patients gained confidence by the 
assurance and counseling given by us about the advantages of breast 
screening.  
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A complete analysis of the datas obtained by the triple assessment 
of these 100 patients was made. The lesions were categorized broadly 
into benign and malignant. Then the incidence of each type of lesions 
were categorized individually.  
 
The following statistical reports were obtained . 
Benign lesions    -  74% 
Malignant lesions  -  26% 
 
 
Fig 7. PERCENTAGE OF BENIGN AND MALIGNANT 
LESIONS 
 
Column1
Benign - 74%
Malignant - 26%
69 
 
 
 
Fig 8. A CASE OF DUCTAL CARCINOMA- RIGHT BREAST 
 
 
     In this study, the benign lesions were more common in the 
younger individuals while the malignant lesions showed increase 
incidence in the elderly individuals. There is an increase in the incidence 
of malignant lesions of the breast. 
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Fig 9. A CASE OF FIBROADENOMA –LEFT BREAST 
 
 
 
 Off the benign lesions, the following results were obtained of 
which Fibroadenoma which accounted for 41 % was the commonest 
lesion. 
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Fig 10. A CASE OF PHYLLOIDES TUMOR- LEFT BREAST 
 
 
Fig 11. A CASE OF KERATOCYST OF BREAST- LEFT SIDE 
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Percentage of benign lesions 
Fibroadenoma   –  41% 
Fibrocystic disease  –  17% 
Phylloides tumour   –  6% 
Fibroadenosis   –  4% 
Keratocyst    –  3% 
Breast abscess   –  2% 
Fat necrosis    –  1% 
 
This confirms the commonest presentation of fibroadenoma among 
the benign lesions. 
 
In this study, the malignant lesions accounted for 26%. All of these 
malignant lesions were of the invasive ductal carcinoma type, however , 
of different grades. This confirms the rarity of other types of breast 
malignancy. 
 
There was no particular geographic variations in the incidence of 
either benign or malignant breast lesions. 
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Fig 12. PERCENTAGE OF VARIOUS BREAST DISEASES 
 
I. FIBROADENOMA;   II. INVASIVE  DUCTAL  CARCINOMA;  III. FIBROCYSTIC  DISEASES;  
IV. PHYLLOIDES  DISEASE ;  V.  FIBROADENOSIS ;  VI. KERATOCYST ;  
 VII.  BREAST ABSCESS ;  VIII.  FAT  NECROSIS 
 
 
All the 100 study groups were advised curative procedures in cases 
of possibilities and for a regular follow-up. In cases of inoperable 
malignant  lesions, they were given palliative measures and advised for 
regular follow up and further management. 
 
All the 26 patients with malignant lesions were advised a screening 
examination of their first degree relatives for early diagnosis and 
management. 
 
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
I
II
III
IV 
V 
VI
VII
VIII
74 
 
 
DISCUSSION 
Since Carcinoma breast is increasing in its incidence world wide 
and in our country, this study will create an awareness of the females in 
this region. It will motivate the patients friends and their relatives to have 
a screen done to rule out breast pathology. A complete cure of the lesions, 
be it a benign or a malignant if diagnosed  early is possible. This study 
helps in seeking awareness of the individuals for early detection and 
management.  
 
For centuries, management of breast cancer was predicated on 
anecdotal experience and the results of retrospective studies. Now, it is 
largely based on the results of randamonized, prospective clinical trails. 
These trails have shown that screening, adjuvant systemic therapy, and 
adjuvant radiotherapy can reduce breast cancer mortality. 
 
In this study, benign lesions are common than malignant lesions.  
Off  the  benign lesions, fibroadenoma is the commonest one especially in 
younger patients. The youngest patient in this study was 17years who was 
diagnosed as fibroadenoma.  
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All the malignant lesions in this study are of the invasive ductal 
carcinoma of varying grades from their histopathological biopsy. This 
shows the rarity of the other types of malignant lesions of the breast. The 
most eldest patient in this study group was 68 years and was diagnosed as 
invasive ductal carcinoma.   
 
There was no geographical significance in the occurrence of either 
benign or malignant breast lesions. 
 
The lesions which on clinical examination were in favour of 
malignant lesions, proved to be  Phylloides tumor in FNAC/ HPE . This 
study proves the 100% diagnostic accuracy of the triple assessment test. 
 
This study clearly has a very favorable effect in improving the 
outcome of women with breast cancer. Thus this study indeed makes 
progress in the treatment of breast diseases and future progress will 
depend on the thoughtful planning of new clinical trials and patient 
participation in those trails. 
 
Screening produces a transient increase in the new cases which can 
be diagnosed earlier. Eventhough the use of mammography is high, the 
breast cancer rates continue to raise. Risk factors such as changes in the  
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age of child bearing, alterations in the average ages of menopause and 
menarche, the wide spread use of harmone replacement therapy and 
genetic factors potentially contributes to the increased incidence. 
 
Continued research into the etiology of breast cancer, both genetic 
and environmental, is important in understanding the rising  incidence 
and in devising interventional strategies to reduce risk. 
 
Early detection, increased use of mammography and improved 
adjuvant therapy of early stage breast cancer will definitely reduce the 
mortality of breast cancer. 
 
Breast cancer is one of the commonest cancers in females in India. 
If these cancers are detected early, it is one of the most curable cancer. 
This study will certainly create an awareness among the females. The 
familiarity with one’s own breast is implicated as breast awareness. All 
females should self examine their breasts at least once a month during 
taking both, best time being the end of her periods. This will certainly 
help in the notice of any lumps, irregularity in the skin over the breast or 
the nipple, etc. Each individual should be aware of the changes that can 
occur in a breast which are likely to be of a pathological conditions.  
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The most prominent symbol of breast cancer awareness is a pink 
ribbon. This ribbon may be worn to honor those individuals who are 
diagnosed as having breast malignancy. 
 
In patients who are diagnosed as malignancy, the treatment never 
ends with surgery and or chemotherapy and or radiotherapy. These 
patient should be advised for a regular follow-up. An intensive follow-up 
comprise of periodic chest X-ray and bone scan for the earlier detection 
of distant metastasis. In the past few years there has been a strong 
demand of many screening programs for breast in India. These programs 
have certainly created an awareness among the educated middle and 
upper class females. 
 
The emotional impact of cancer diagnosis, symptoms, treatment 
and related issues can be severe. The cancer support groups provide a 
supportive and a peaceful environment for the patients of breast cancer. 
Since breast cancer is common in the older individuals, this geriatric issue 
warrants further research awareness of the individuals and cancer support 
services for these patients 
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The mortality from breast cancer reduces by 33% by routine use of 
screening mammography in women of more than 50years of age. This 
reduction comes without substantial risks and at an acceptable economic 
cost. The screening mammography in women less than 50years of age is 
however more controversial because of breast density is greater and 
screening mammography is less likely to detect early breast cancer; 
screening mammography results in more false positive test findings, 
resulting in unnecessary biopsies; and younger females are less likely to 
have breast malignancy, so fewer young females will be benefited by 
screening.  
 
 However, on a population basis the benefits of screening 
mammography in younger women still appear to outweigh the risks.  
 
Breast cancer mortality trend has changed after the introduction of 
screening. Studies show that there is definitely better outcome in women 
of breast cancer who had a prior screening than those who did not have. 
Mammographic screening causes a significant shift in tumour size 
distribution from predominantly large to predominantly small. 
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The death rate from breast cancer can be reduced by decreasing the 
rate of advanced cancers. The incidence of advanced cancers thus seems 
as the most predictive measure of success or failure of a screening 
program. High quality mammography screening detects tumours of even 
5mm size. Hence high quality mammography plays a vital role in 
diagnosing impalpable lesions that are still localized to the breast. 
 
Ultrasound of the breast also plays a vital role in the diagnostic 
evaluation of benign and malignant breast conditions, other than for its 
screening purpose in young females. 
 
Although genetic alterations may directly affect only a small 
percentage of women with breast cancer, the advent of molecular 
profiling for breast cancer may in the future allow us to identify women 
at risk before breast cancer develops and permit targeted interventions. 
 
Women should be encouraged to continue regular screening and to 
participate in clinical trials if possible to devise more specific and 
effective preventive strategies to benefit most women.   
 
80 
 
 
CONCLUSION 
 
 In  this  study  of  100  females  of  symptomatic  breast  lesions,  74%  
are  of  Benign diseases and  26%  are  of  Malignant lesions. 
 
 The benign  lesions  are  common  in  the  young  individuals and  
fibroadenoma  is  the  commonest  benign  lesion  in  this  study group. 
 
 The  incidence  of  malignant  lesions  are  common  in  the elder  
individuals  and  most  of  the  lesions  are  of  the  invasive ductal  
carcinoma  of  different  grades.  
 
 The  other  benign  lesions are  fibrocystic  disease,  phylloides  tumor,  
fibroadenosis, keratocyst,  breast  abscess  and  fat  necrosis. 
 
 Triple  assessment  consisting  of  clinical  examination, radiological  
imaging  and  FNAC/HPE  is  the  best  clinical  approach to the  early 
diagnosis and management of patients with breast lesions. 
 
 Early screening and diagnosis of breast lesions will reduce the 
morbidity and mortality due to breast lesions. 
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From this study it is inferred that there is an increase in the 
incidence of the Breast cancer in this region and early diagnosis and 
treatment is the key to reduce the morbidity and mortality.       
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PROFORMA 
 
Name : 
Age : 
OP No. : 
Address : 
 
 
Occupation    :      Income  : 
 
Chief Complaints : 
1. Pain  
2. Lump 
3. Heaviness of Breast 
 
History of Present Illness : 
1. Lump 
2. Pain 
3. Discharge from Nipple 
4. Retraction of Nipple 
5. Loss of Weight 
 
Past History :  
1. Recurrence of Abscess 
2. Carcinoma of other breast 
3. H/O DM/ HT/ IHD/ Drugs/ COPD 
 
 
Personal History : 
1. Marital Status 
2. Age of menarche or menopause 
3. Menstrual history 
4. Lactational history 
5. Diet 
6. Smoking 
7. Alcohol consumption 
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Family History : 
H/O breast diseases in family members 
 
Local Examination : 
 
INSPECTION : 
1. Breasts 
2. Nipple 
3. Areola 
4. Arm and Thorax 
5. Axilla and Supraclavicular fossa 
 
PALPATION  : 
 
In presence of lump 
1. Local examination 
2. Situation 
3. Number 
4. Size & Shape 
5. Surface 
6. Margin 
7. Consistency 
8. Fluctuation 
9. Fixity to skin, breast tissue, underlying muscles, chest wall 
 
EXAMINATION OF LYMPH NODES 
 
A. Palpation of Axillary group of Lymph nodes 
1. Pectoral group 
2. Brachial group 
3. Subscapular group 
4. Central group 
5. Apical group  
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B. Palpation of cervical Lymph nodes 
 
 
GENERAL EXAMINATION: 
1. Lungs 
2. Bones 
3. Liver 
4. Rectum and Vagina 
 
 
INVESTIGATIONS : 
1. Blood examination  
2. Radiology 
–  Ultrasonogram of breast 
–  Mammography 
3. Pathology  
–  FNAC 
                        –  Core Needle Biopsy 
 
 
DIAGNOSIS  : 
A. Clinical     B. Radiological   C. Pathological 
 
 
FINAL DIAGNOSIS :   
 
TREATMENT    : 
 
FOLLOW-UP      : 
 
 
MASTER  CHART 
 No. Name age OP No. Address SES Complaints Duration CL. Finding   USG /Mamo Fnac / cytology Diagnosis 
1. Vijayalakshmi 48 473839 Sullur Low Pain  RB 6 months 1x1cm cystic mass BIRADS II Keratocyst Keratocyst –RB 
2. Saradha 43 459574 Allandurai Low Lump RB 2 years 3x2cm cystic mass BIRADS II Fibrocystic dis Fibrocystic lesion RB 
3. Selvi 41 118041 Sundapala Low Lump LB 3 months 4x3cm hard mass BIRADS V Inva .Duc .Ca Inva.Duc.Ca LB 
4. Rangammal 68 605008 Narasepu 
ram 
Low Lump LB 1 year 5x3cm hard mass 
2x2cm ant.axi.LN  
BIRADS V Ductal.Ca Inva.Duc.Ca LB 
5. Padmavathy 30 123341 Kuniyamuthr Low Lump RB 2 months 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
6. Kavitha 37 651813 Sungam Low  Pain RB 15 days 2x1cm cystic mass BIRADS II Fibrocystic dis Fibrocystic dis RB 
7. Kuppulakshmi 59 95442 Perur Low Pain LB 8 months 3x2cm hard mass BIRADS V Ductal Ca Ductal Ca LB 
8. Rejina 30 239363 Kamraj nagar Low Lump LB 2 yrs 4x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
9. Kavitha 46 350113 Kongu Nagar Low LuminessRB 2months 4x3cm diffu mass BIRADS II Fibroadenosis Fibroadenosis  RB 
10. Shakunthala 46 265013 Sam.puram Low Lump RB 3years 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
11 Malathy 39 252371 Tiruvall st. Low Lump LB 1 Year 4x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
12. Sabeerabanu 25 474422 Pacapalyam Low Pain LB 6 months 2x2cm cystic mass BIRADS II Fibrocystic  dis. Fibrocystic dis  LB 
13. Angathal 65 395962 Koun.payam Low Lump RB 6 years 5x4cm hard mass BIRADS V Ductal.Ca Inva.Duct.Ca RB 
14. Lakshmi 51 6051123 S.S.kulam Low Lump LB 5months 3x3cm hard mass BIRADS IV Ductal. Ca Inva.Duct. Ca LB 
15. Vennila 38 557273 Kurumathur Low Lump RB 15 days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma  RB 
16. Lakshmi 40 541547 Nalvarnagar Low Pain LB 1month 3x2cm cystic mass BIRADS II Fibrocystic .dis. Fibrocystic dis LB 
17. Sundarambal 49 575132 Masallayout Low Pain RB 3months 2x2 firm mass BIRADS II Fibrocystic .dis Fibrocystic dis.RB 
18. Vijayarani 44 576925 Thudiyalur Low Pain LB 2months 2x2cm cystic mass BIRADS II Keratocyst Keratocyst LB 
19 Punitha 37 665614 Kangainur Low Lump LB 15 days 3x2cms diff.mass BIRADS II Fibroadenoma Fibroadenoma LB 
20. Lakshmi 57 575201 S.S.nagar Low Lump RB 6months 4x3cm hardmass 
2x2cm ant.axi.LN 
BIRADS IV Ductal Ca. Inva.Duct Ca RB 
21. Revathy 17 218826 Singanallur Low Lump LB 1month 3x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
22. Periyanayagi 55 473217 Podanur Low Lump LB 1year 3x2cm hard mass BIRADS IV Ductal Ca Inva. Duct Ca LB 
23. Karpagam 32 279672 Ondipudur Low HeavinessLB 5months 2x2cm firm mass BIRADS II Fibrocystic dis. Fibrocystic dis.LB 
24.` Gomathy 20 491719 Velanthavalm Low Lump RB 15days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
25 Sarasu 33 547359 Viiankuruchi Low Pain LB 1month 3x2cm hard mass BIRADS IV Ductal Ca. Inva.Ductal Ca LB 
 No. Name age OP No. Address SES Complaints Duration CL. Finding   USG /Mamo Fnac / cytology Diagnosis 
26 Kunjammal 36 542693 Perur Low HeavinessLB 6months 4x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
27. Mythili 19 487453 Kuruchi Low Lump RB 10days 2x1cm firm mass BIRADS II Fibroadenoma Fibroadenoma  RB 
28 Buvaneshvari 20 302690 Allandurai Low  Lump LB 15days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
29 Priya 23 574818 Sitra Low Pain RB 6months 3x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
30. Rajeshwari 22 574573 Verakeralam Low Pain RB 7days 1x1cm cystic mass BIRADS II Fibrocystic dis. Fibrocystic dis.RB 
31 Jayapriya 24 576572 Madukarai Low HeavinessLB 15days Diffuse firm mass BIRADS II Fibrocystic dis. Fibrocystic dis.LB 
32 Sandhiya 23 63760 Katuchetilane Low HeavinessRB 2months 3x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
33 Latha 30 61937 Swamipuram Low Pain LB 20days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
34 Noorjahan 56 229596 Gurunath st. Low Lump LB 2years 4x3cm hard mass 
2x2cm ant.axi.LN 
BIRADS IV Ductal Ca. Inva.Ductal Ca.LB 
35 Selvi 27 14987 Selvapuram Low Pain RB 15days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
36 Pushpavalli 56 62790 Ondipudur Low Pain RB 2years 3x2cm hard mass BIRADS IV Ductal Ca. Inva.Ductal Ca.RB 
37 Lalitha 47 8064 Ediyarpalayam Low Pain LB 15days 2x2cm cystic mass BIRADS II Fibrocystic dis. Fibrocystic dis.LB 
38 Jothy 32 1509 Va .puram Low  Lump LB 10days 3x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
39 Arokya rani 17 11229 S.S.kulam Low Lump RB 7days 2x1cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
40 Rangal 37 8172 Ondipudur Low HeavinessRB 1month 5x3cm diff.mass  BIRADS II Fibrocystic dis. Fibrocystic dis.RB 
41 Rani 48 84997 Madukarai Low Lump LB 20days 2x1cm hard mass BIRADS III Ductal Ca. Inva.Ductal Ca. LB 
42 Saraswathy 50 212415 Vadavalli Low HeavinessRB 1year 3x3cm cystic mass BIRADS II Fibrocystic dis. Fibrocystic dis.RB 
43 Sumathy 27 18224 Perur Low Lump LB 7days 1x1cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
44 Vijayalaxmi 38 26381 V.palayam Low Lump RB 10days 1x1cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
45 Jerina 45 185571 Irrugur Low Lump LB 1year 2x2cm hard mass 
1x1cm ant.axi.LN 
BIRADS IV Ductal Ca. Inva.Ductal Ca. LB 
46 Deivanai 47 21278 Allandurai Low Lump RB 3years 3x3cm hard mass 
2x2cm cen.axi.LN 
BIRADS IV Ductal Ca Inva.Ductal Ca.RB 
47 Nagarathinam 50 16644 Vedapatti Low  Lump LB 1year 4x3cm hard mass BIRADS IV Ductal Ca Inva.Ductal Ca.LB 
48 Jothilakshmi 36 3964 Sungam Low Lump RB 3months 2x2cm hard mass BIRADS IV Ductal Ca. Inva. Ductal Ca.RB 
49 Bannari 40 8109 Veerakerlam Low Lump RB 1year 8x6cm firm mass BIRADS III Phylloides  tr. Phylloides tumor RB 
50 Kulanthaiamal 42 21654 Veerakerlam Low Pain RB 15 days 3x2cm hard mass BIRADS IV Ductal Ca Invasive Ductal Ca RB 
 No. Name age OP No. Address SES Complaints Duration CL. Finding   USG /Mamo Fnac / cytology Diagnosis 
51 Pongodi 18 208401 Sulur Low  Pain RB 7 days  1x1cm firm mass  BIRADS II fIbroadenoma Fibroadenoma  RB 
52 Selvi 22 219541 Avarampalym Low Pain RB 3days 3x3cm cystic mass BIRADS II Abscess Abscess RB 
53 Gomathy 18 33381 Sowripalyam Low Lump RB 7days  3x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
54 Sharadha 56 25359 Goundthotam Low Lump LB  6months 3x3cm hard mass 
2x2cm ant.axi.LN 
BIRADS V Ductal Ca Inva.Ductal Ca.LB 
55 Mani 56 26309 Verakerlam Low Lump RB 6 months 6x5cm hard mass BIRADS III Phylloides tr. Phylloides tr.RB 
56 Rukumani 66 272278 Edayarpalyam Low Lump LB 3 months 5x3cm hard mass 
1x1cm ant.axi.LN 
BIRADS IV Ductal Ca Inva.Ductal Ca LB 
57 Poongodi 18 30279 Nanju.puram Low  Pain RB 7 days 6x5cm diff.mass BIRADS II Fibroadenoma Fibroadenoma RB 
58 Selvi 19 46559 Sungam Low Pain LB 10 days 2x2cm firm mass BIRADS  II Fibroadenoma Fibroadenoma LB 
59 Padmavathy 48 21456 Erugur Low HeavinessLB 1 month 5x3cm diff.mass BIRADS II Fibroadenosis Fibroadenosis LB 
60 Nagalakshmi 50 60136 Karamadai Low Pain LB 15 days 2x2cm cystic mass BIRADS II Fibrocystic  dis. Fibrocystic dis. LB 
61 Poongodi 49 58522 Kuruchi pirvu Low Lump RB 2 months 6x5cm hard mass BIRADS III Phylloides tr. Phylloides tr. RB 
62 Sundarambal 56 51115 Karadimadai Low Pain LB 3 months 8x6cm hard mass BIRADS III Phylloides tr. Phylloides tr. LB 
63 Palaniyammal 41 71644 Kovilpalyam Low Lump LB 10days 4x3cm hard mass BIRADS IV Ductal Ca Inva.Ductal Ca LB 
64 Kalyani 37 71598 Kondanur Low Lump LB 1 month 10x8cm firm mass BIRADS III Phylloides tr. Phylloides tr. LB 
65 Palaniyammal 41 54782 Singanallur Low Pain LB 15 days 2x1cm cystic mass BIRADS II Fibrocystic dis. Fibrocystic dis. LB 
66 Sivagami 45 64381 RN puram Low Pain LB 7 days 3x2cm firm mass BIRADS II Fat necrosis Fat necrosis LB 
67 Krishnaveni 45 557011 Kongunagar Low Pain RB 15 days 6x3cm firm mass  BIRADS II Fibroadenoma  Fibroadenoma RB 
68  Devi 30 56752 Karamadai Low Lump RB 20 days 4x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
69 Saraswathy 52 343016 Karadimadai Low Lump RB 2 months 6x4cm firm mass BIRADS II Fibroadenoma  Fibroadenoma RB 
70 Kanagathal 47 318603 Patchapalyam Low Pain RB 7 days 3x3cm diff.mass BIRADS II Fibrocystic dis. Fibrocystic dis. RB 
71 Munni 45 31256 Annur Low Pain LB 2 months 3x3cm diff.mass BIRADS II Fibroadenosis Fibroadenosis LB 
72 Latha 50 213542 Selvapuram Low Lump RB 6 months 5x4cm hard mass BIRADS II Fibroadenoma Fibroadenoma RB 
73 Saroja 65 213323 Kuruchipirivu Low Pain RB 10 days 4x2cm cystic mass BIRADS II Fibrocystic dis. Fibrocystic dis. RB 
74 Pushparani 31 812732 Pn palyam Low Lump RB 15 days  5x4cm firm mass BIRADS II Fibroadenoma  Fibroadenoma RB 
75 Kanchana 45 379423 Irugur Low Lump LB 1 month 4x3cm hard mass BIRADS IV Ductal Ca. Inva.Ductal ca. LB 
 No. Name age OP No. Address SES Complaints Duration CL. Finding   USG /Mamo Fnac / cytology Diagnosis 
76 Rajam 61 516232 Vanniur St Low Lump LB 5 months 3x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma  LB 
77 Veda 23 551261 Sidapudur Low Pain LB 5 months 4x3cm diff.mass BIRADS II Fibroadenosis Fibroadenosis LB 
78 Selvi 41 1251106 Papampatty Low  Lump RB 6 months 3x2cm hard mass BIRADS IV Ductal Ca Inva.Ductal Ca RB. 
79 Kuppulakshmi 59 1412761 Periyar nagar Low  Lump LB 2 years 5x3cm hard mass BIRADS IV Ductal Ca. Inva. Ductal Ca. LB 
80  Mallika 34 516234 P N palyam Low Lump LB 15 days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
81 Myilamal             45 475143 Vysial St. Low Lump RB  20days 5x4cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
82 Jothilakshmi 38 516149 Annur Low Lump RB  1 month  6x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
83 Lakshmi  51 371654 Seiranpalyam Low Lump RB 3 months 3x2cm hard mass BIRADS IV Ductal Ca. Inva. Ductal Ca. RB 
84 Padmavathy 30 48317 Pachapalyam Low  Pain LB 7 days  5x3cm cystic mass BIRADS II Fibroadenoma Fibroadenoma LB 
85 Buvaneswari 26 160313 S.S. Kulam  Low Pain LB 3 days 2x1cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
86 Dhanya 21 179813 Thondamutur Low  Lump RB 10 days  2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
87  Sakuntala 46 141013 Arasur Low Pain RB 3 months 5x4cm diff. mass BIRADS II Fibrocystic dis. Fibrocystic dis. RB 
88 Shanthi 35 280852 Puliyampati Low Pain RB 5 days  4x3cm cystic mass BIRADS II Abscess Abscess RB 
89 Kanagathal 47 3117513 Kinatukadavu Low Lump RB 1 month 5x3cm diff. mass BIRADS II Fibrocystic dis. Fibrocystic dis.RB 
90 Puspavalli 56 1093012 Annur Low Lump RB 6 months 5x4cm hard mass BIRADS IV Ductal Ca. Inva. Ductal. Ca. RB 
91 Vijayalaxmi 48 473889 Siva colony Low Lump RB 15 days 1x1cm cystic mass  BIRADS II Keratocyst Keratocyst RB 
92 Angathal  65 39596 S.S.Kulam Low Lump RB  2 years 6x5cm hard mass 
2x2cm ant.axi.LN 
BIRADS IV Ductal Ca. Inva. Ductal Ca. RB 
93 Periyanagi 55 43799 Nalvarnagar Low Lump LB 6 months 4x3cm hard mass BIRADS IV Ductal Ca. Inva. Ductal Ca. LB 
94 Sharada 43 42164 Kurumathur Low  Lump RB 15 days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
95 Vijaya 47 50468 Appanpalyam Low Lump RB 2 months 5x4cm firm mass BIRADS II Fibroadenoma  Fibroadenoma RB 
96 Vannilla 43 49923 Vellalur Low Lump RB 3 months 8x5cm firm mass BIRADS III Phylloides tr. Phylloides tr. RB 
97 Kunjammal 36 48337 B.K.pudur Low Pain LB 10 days 3x3cm firm mass BIRADS II Fibroadenoma Fibroadenoma LB 
98 Saraswathy 52 36087 Madukkarai Low  Lump RB 15 days 4x3cm firm mass BIRADS II Fibroadenoma  Fibroadenoma RB 
99 Gowri 40 557268 Edayarpalyam Low Lump RB 7 days 2x2cm firm mass BIRADS II Fibroadenoma Fibroadenoma RB 
100 Kamithabevi 19 558485 Ukkadam Low Lump RB 7days 3x3cm firm mass BIRADS II Fibroadenoma  Fibroadenoma RB 
     
SES  -  Socio Economic Status   ;  USG   -  Ultra Sound ;   Mamo   -   Mammography  ;  BIRADS  - Breast  Imaging  Reporting  and  
Data  System  ;  Inva. Duc. Ca  -  Invasive  Ductal  Carcinoma ;  LB  - Left  Breast ;  RB  -  Right  Breast  ;  Dis  - Disease ;  tr - Tumor 
